Skip to contentI
ICU Medical Inc
I
ICUIICU Medical Inc Q3 2023 · 10-Q
Revenue$553.31M$553.31M−7.5% vs Q3 2022 Net Income$7.24M$7.24MN/M vs Q3 2022 EPS Diluted$0.30$0.30N/M vs Q3 2022 Gross Profit$183,920,000−1.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ICU Medical Inc · CIK 883984 · Engraved from SEC EDGAR
Operating Cash Flowderived$35,161,000+1,422.8% Free Cash Flowderived$13,694,000N/M Margins · derivedGross margin33.2%+2.1 pt vs Q3 2022
Operating margin4.1%+4.2 pt vs Q3 2022
Net margin1.3%+3.5 pt vs Q3 2022
ended Sep 30, 2023 · filed Nov 6, 2023 · 37 d after period end